Controlling Dengue with Vaccines in Thailand

PLoS Neglected Tropical Diseases

Volumn 6, Issue 10, 2012, Pages

  Chao, Dennis L ^a   Halstead, Scott B ^b   Halloran, M Elizabeth ^a,c   Longini, Ira M ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Dengue Vaccine Initiative   (South Korea)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE;

AEDES AEGYPTI; AGE DISTRIBUTION; ARTICLE; COMPUTER SIMULATION; DENGUE; DISEASE CONTROL; DISEASE TRANSMISSION; EXPOSURE; HOSPITALIZATION; IMMUNE STATUS; INCIDENCE; INCUBATION TIME; MATHEMATICAL MODEL; MOSQUITO; PHASE 2 CLINICAL TRIAL (TOPIC); PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY INFECTION; SEROTYPE; THAILAND;

EID: 84869027517     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001876     Document Type: Article

References (56)

1. World Health Organization (2007) Report of the Scientific Working Group meeting on dengue. Available: http://apps.who.int/tdr/svc/publications/tdr-research-publications/swgreport- dengue Accessed 2012 Feb 22.
2. Gubler DJ, (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-96.
3. Lum LCS, Suaya JA, Tan LH, Sah BK, Shepard DS, (2008) Quality of life of dengue patients. Am J Trop Med Hyg 78: 862-7.
4. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH, (2011) Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 84: 200-7.
5. Martelli CM, Nascimento NE, Suaya JA, Siqueira JB Jr, Souza WV, et al. (2011) Quality of life among adults with confirmed dengue in Brazil. Am J Trop Med Hyg 85: 732-8.
6. Heintze C, Velasco Garrido M, Kroeger A, (2007) What do community-based dengue control programmes achieve? A systematic review of published evaluations. Trans R Soc Trop Med Hyg 101: 317-25.
7. Horstick O, Runge-Ranzinger S, Nathan MB, Kroeger A, (2010) Dengue vector-control services: How do they work? A systematic literature review and country case studies. Trans R Soc Trop Med Hyg 104: 379-86.
8. Esu E, Lenhart A, Smith L, Horstick O, (2010) Effectiveness of peridomestic space spraying with insecticide on dengue transmission; systematic review. Trop Med Int Health 15: 619-31.
9. Monath TP, (2001) Yellow fever: an update. Lancet Infect Dis 1: 11-20.
10. Halstead SB (2008) Epidemiology. In: Halstead SB, editor, Dengue, London: Imperial College Press. pp. 75-122.
11. Schmitz J, Roehrig J, Barrett A, Hombach J, (2011) Next generation dengue vaccines: A review of candidates in preclinical development. Vaccine 29: 7276-84.
12. Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, et al. (2011) From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine 29: 7229-41.
13. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, et al. (2012) Protective effcacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet In press.
14. Halloran ME, Longini IM Jr, Struchiner CJ (2010) Design and analysis of vaccine studies. New York: Springer.
15. Ferguson NM, Donnelly CA, Anderson RM, (1999) Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Philos Trans R Soc Lond B Biol Sci 354: 757-68.
16. Cummings DAT, Schwartz IB, Billings L, Shaw LB, Burke DS, (2005) Dynamic effects of antibodydependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A 102: 15259-64.
17. Adams B, Holmes EC, Zhang C, Mammen MP Jr, Nimmannitya S, et al. (2006) Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A 103: 14234-9.
18. Yasuno M, Tonn RJ, (1970) A study of biting habits of Aedes aegypti in Bangkok, Thailand. Bull World Health Organ 43: 319-25.
19. Focks DA, Daniels E, Haile DG, Keesling JE, (1995) A simulation model of the epidemiology of urban dengue fever: literature analysis, model development, preliminary validation, and samples of simulation results. Am J Trop Med Hyg 53: 489-506.
20. Halstead SB, Nimmannitya S, Yamarat C, Russell PK, (1967) Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol 20 Suppl: 96-103.
21. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, et al. (2010) Crossreacting antibodies enhance dengue virus infection in humans. Science 328: 745-8.
22. Murphy BR, Whitehead SS, (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29: 587-619.
23. Halstead SB, (2012) Dengue vaccine development: a 75% solution? Lancet In press.
24. Thomas SJ, Endy TP, (2011) Critical issues in dengue vaccine development. Curr Opin Infect Dis 24: 442-50.
25. Beatty M, Boni MF, Brown S, Buathong R, Burke D, et al. (2012) Assessing the potential of a candidate dengue vaccine with mathematical modeling. PLoS Negl Trop Dis 6: e1450.
26. Sabin AB, (1952) Research on dengue during World War II. Am J Trop Med Hyg 1: 30-50.
27. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
28. Center for International Earth Science Information Network (CIESIN), Columbia University; International Food Policy Research Institute (IPFRI); the World Bank; and Centro Internacional de Agricultura Tropical (CIAT) (2004). Global rural-urban mapping project, version 1 (GRUMPv1). Available: http://sedac.ciesin.columbia.edu/gpw/.
29. Cummings DAT, Iamsirithaworn S, Lessler JT, McDermott A, Prasanthong R, et al. (2009) The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling. PLoS Med 6: e1000139.
30. Salje H, Lessler J, Endy TP, Curriero FC, Gibbons RV, et al. (2012) Revealing the microscale spatial signature of dengue transmission and immunity in an urban population. Proc Natl Acad Sci U S A 109 (24):: 9535-8.
31. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, et al. (2003) Serotypespecific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191-202.
32. Thai KTD, Binh TQ, Giao PT, Phuong HL, Hung LQ, et al. (2005) Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop Med Int Health 10: 379-86.
33. Tien NTK, Luxemburger C, Toan NT, Pollissard-Gadroy L, Huong VTQ, et al. (2010) A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans R Soc Trop Med Hyg 104: 592-600.
34. Halstead SB, (2008) Dengue virus-mosquito interactions. Annu Rev Entomol 53: 273-91.
35. Sanchez L, Vanlerberghe V, Alfonso L, del Carmen Marquetti M, Guzman MG, et al. (2006) Aedes aegypti larval indices and risk for dengue epidemics. Emerg Infect Dis 12: 800-6.
36. Pham HV, Doan HTM, Phan TTT, Minh NNT, (2011) Ecological factors associated with dengue fever in a Central Highlands province, Vietnam. BMC Infect Dis 11: 172.
37. Wichmann O, Yoon IK, Vong S, Limkittikul K, Gibbons RV, et al. (2011) Dengue in Thailand and Cambodia: An assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis 5: e996.
38. Sabchareon A, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, et al. (2012) Dengue infection in children in Ratchaburi, Thailand: A cohort study. I. Epidemiology of symptomatic acute dengue infection in children, 2006-2009. PLoS Negl Trop Dis 6: e1732.
39. Meltzer MI, Rigau-Pérez JG, Clark GG, Reiter P, Gubler DJ, (1998) Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. Am J Trop Med Hyg 59 (2):: 265-71.
40. Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, et al. (2005) Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am J Trop Med Hyg 72 (1):: 60-6.
41. Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, et al. (2007) Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg 77 (5):: 910-3.
42. Zorlu G, Fleck F, (2011) Dengue vaccine roll-out: getting ahead of the game. Bull World Health Organ 89: 476-7.
43. Wearing HJ, Rohani P, (2006) Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci U S A 103 (31):: 11802-7.
44. Stoddard ST, Morrison AC, Vazquez-Prokopec GM, Soldan PV, Kochel TJ, et al. (2009) The role of human movement in the transmission of vector-borne pathogens. PLoS Negl Trop Dis 3: e481.
45. Barmak DH, Dorso CO, Otero M, Solari HG, (2011) Dengue epidemics and human mobility. Phys Rev E Stat Nonlin Soft Matter Phys 84: 011901.
46. Zhang C, Mammen MP Jr, Chinnawirotpisan P, Klungthong C, Rodpradit P, et al. (2005) Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J Virol 79: 15123-30.
47. Johansson MA, Hombach J, Cummings DAT, (2011) Models of the impact of dengue vaccines: A review of current research and potential approaches. Vaccine 29: 5860-8.
48. World Health Organization (2012). Dengue and severe dengue: Fact sheet number 117. Available at http://www.who.int/mediacentre/factsheets/fs117/en/index.html (accessed February 22, 2012).
49. Amarasinghe A, Wichmann O, Margolis HS, Mahoney RT, (2010) Forecasting dengue vaccine demand in disease endemic and non-endemic countries. Human Vaccines 6: 745-53.
50. Shepard DS, Suaya JA, Halstead SB, Nathan MB, Gubler DJ, et al. (2004) Cost-effectiveness of a pediatric dengue vaccine. Vaccine 22 (9-10):: 1275-80.
51. Lee BY, Connor DL, Kitchen SB, Bacon KM, Shah M, et al. (2011) Economic value of dengue vaccine in Thailand. Am J Trop Med Hyg 84: 764-72.
52. Al-Muhandis N, Hunter PR, (2011) The value of educational messages embedded in a communitybased approach to combat dengue fever: A systematic review and meta regression analysis. PLoS Negl Trop Dis 5: e1278.
53. Phuc HK, Andreasen MH, Burton RS, Vass C, Epton MJ, et al. (2007) Late-acting dominant lethal genetic systems and mosquito control. BMC Biol 5: 11.
54. Kambris Z, Cook PE, Phuc HK, Sinkins SP, (2009) Immune activation by life-shortening Wolbachia and reduced filarial competence in mosquitoes. Science 326: 134-6.
55. Fu G, Lees RS, Nimmo D, Aw D, Jin L, et al. (2010) Female-specific ightless phenotype for mosquito control. Proc Natl Acad Sci U S A 107: 4550-4.
56. Walker T, Johnson PH, Moreira LA, Iturbe-Ormaetxe I, Frentiu FD, et al. (2011) The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature 476: 450-3.